US20050080136A1 - Powder of amino acids and method for producing the same - Google Patents
Powder of amino acids and method for producing the same Download PDFInfo
- Publication number
- US20050080136A1 US20050080136A1 US10/921,895 US92189504A US2005080136A1 US 20050080136 A1 US20050080136 A1 US 20050080136A1 US 92189504 A US92189504 A US 92189504A US 2005080136 A1 US2005080136 A1 US 2005080136A1
- Authority
- US
- United States
- Prior art keywords
- powder
- amino acid
- amino acids
- trehalose
- spray drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 123
- 239000000843 powder Substances 0.000 title claims abstract description 109
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 57
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 50
- 238000001694 spray drying Methods 0.000 claims abstract description 47
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 46
- 239000002245 particle Substances 0.000 claims abstract description 44
- 239000007788 liquid Substances 0.000 claims abstract description 43
- 239000007921 spray Substances 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 34
- 238000005469 granulation Methods 0.000 claims description 30
- 230000003179 granulation Effects 0.000 claims description 30
- 230000008569 process Effects 0.000 claims description 4
- 150000003625 trehaloses Chemical class 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- 238000001035 drying Methods 0.000 abstract description 11
- 229940024606 amino acid Drugs 0.000 description 92
- 235000001014 amino acid Nutrition 0.000 description 92
- 229940074410 trehalose Drugs 0.000 description 37
- 239000000243 solution Substances 0.000 description 25
- 239000000203 mixture Substances 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 15
- 239000007789 gas Substances 0.000 description 15
- 239000012530 fluid Substances 0.000 description 11
- 238000007908 dry granulation Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 8
- 229960000310 isoleucine Drugs 0.000 description 8
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 7
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 6
- 235000019596 Masking bitterness Nutrition 0.000 description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 6
- 239000004744 fabric Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 239000004474 valine Substances 0.000 description 6
- 238000002441 X-ray diffraction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- 150000003862 amino acid derivatives Chemical class 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000011812 mixed powder Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- -1 amino acid salts Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 150000004683 dihydrates Chemical class 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000000873 masking effect Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000000634 powder X-ray diffraction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 206010062237 Renal impairment Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 230000000386 athletic effect Effects 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- DPVHGFAJLZWDOC-PVXXTIHASA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol;dihydrate Chemical compound O.O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DPVHGFAJLZWDOC-PVXXTIHASA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 241001131796 Botaurus stellaris Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- HDTRYLNUVZCQOY-BTLHAWITSA-N alpha,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-BTLHAWITSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-NCFXGAEVSA-N beta,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-NCFXGAEVSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000020879 medical diet Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000012476 oxidizable substance Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940074409 trehalose dihydrate Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to powders of amino acids, which is a microfine or granulated amino acid powder containing trehalose.
- the present invention further relates to methods for producing such powders.
- amino acids amino acid salts, and amino acid derivatives (simply referred to as amino acids hereinafter) are widely used in medical diets for nutrition supplements, disease-specific amino acid preparations for oral administration and infusion for subject patients with renal impairment and liver disorders, infantile nutritious compositions, diet food materials, health foods, and functional foods. Further, amino acids are used in cosmetics and in veterinary preparations for dosing to animals, after being mixed in feeds and the like.
- Trehalose when contained in amino acids, not only serves as a saccharide nutrient but also suppresses the bittern taste of amino acids, advantageously, without any occurrence of the Maillard reaction (browning reaction). Therefore, the presence of trehalose therein is recommended. Specifically, those formulations described below are known.
- trehalose-coated (film) powders of amino acids are known, and may be prepared by one of the following methods.
- a binder is added to a powder of amino acids in mixture to prepare granules by an extrusion granulation process, and the granules surfaces are then coated with trehalose as a coating material by fluid granulation.
- trehalose and a binder are added to a powder of amino acids in mixture for coating by fluid granulation, and spraying an aqueous ethanol solution over the resulting coated powder for granulation (see, JP-A-6-227975).
- amino acid food products containing trehalose which are adjusted to a pH 3.0 to 6.0 by the addition of sour agents such as citric acid so as to prevent flavor deterioration due to heating of the amino acid, or flavor modification or color modification of the amino acid during long-term storage.
- sour agents such as citric acid
- compositions for use in the suppression of blood amino acid variation following vigorous athletic motion a hydrous solution of a composition of amino acids and sugar is disclosed, which contains at least 13 types of amino acids and trehalose.
- the hydrous solution is said to be effective for the improvement of athletic potential and the amelioration of fatigue (see, JP-A-2000-72669).
- the spray drying method is capable of producing microfine particles, and is a dry method for recovering a dry powder of spherical and spherical shell-shaped powder, by dispersing a solution or a particle slurry into the form of microfine particles in hot air, where the spray method uses pressure nozzle, rotating disk, and two-fluid nozzle and the like.
- the mean particle size of the dry powder is about 20 ⁇ m to 500 ⁇ m (see, Handbook of Chemistry and Engineering , revised sixth edition, p. 770, p.
- an inhalation dry composition containing the pharmacologically active component, interferon, as the essential component and containing a hydrophobic amino acid selected from leucine, isoleucine, and valine at 60% or more to less than 100% (mean particle size (volume-based distribution) of 0.1 ⁇ m or more to 10 ⁇ m or less) is disclosed for the purpose of avoiding the deliquescence of the inhalation dry composition, when left at a high humidity (see, JP-A-9-235238).
- Example 2 of JP-A-9-2352308 a dry particle powder is obtained as a control, by preparing a solution containing 3.5 g of isoleucine, 0.7 g of serum albumin, 695.8 g of deionized water, and 300 g of ethanol for spray drying, and then spraying the resulting solution with a spray dryer (aerodynamic mean particle size of 0.9897 ⁇ m).
- a spray dryer anodynamic mean particle size of 0.9897 ⁇ m.
- this Example does not include any description of oral meltability, solubility, and taste masking.
- novel dry powders meaning microfine powder or granulated powder
- amino acids which have great oral meltability and solubility and a high masking effect of the taste.
- a method for producing a powder of amino acids comprising spray drying a hydrous liquid of amino acids to produce a powder of amino acids, where the hydrous liquid of amino acids is prepared into the form of microfine liquid droplets in the presence of trehalose for spray drying to prepare a powder having a mean particle size (Mean Volume Diameter) of 0.1 ⁇ m to 15 ⁇ m.
- a method for producing a powder of amino acids comprising spray drying a hydrous liquid of amino acids to produce a powder of amino acids, where the hydrous liquid of amino acids is prepared into the form of microfine liquid droplets in the presence of trehalose for spray drying, and the resulting powder is then granulated and dried during spray drying or after spray drying, to prepare a granulated powder having a mean particle size (Mean Volume Diameter) of 20 ⁇ m to 1,000 ⁇ m.
- FIG. 1 depicts two X-ray diffraction charts, in which the upper line is the X-ray powder diffraction pattern of the spray dry granulated powder of Example 1 and the lower line is the X-ray powder diffraction pattern of the mixed powder before drying of Comparative Example 2; and
- FIG. 2 depicts three X-ray diffraction charts, in which the upper line is the X-ray diffraction pattern of trehalose; the middle line is the X-ray diffraction pattern of “the mix powder of amino acids” used as the raw materials of Comparative Example 2; and the lower line is the X-ray diffraction pattern of hydroxypropyl cellulose.
- the present invention provides novel powders comprising amino acids and methods of producing such powders.
- novel powders comprising amino acids and methods of producing such powders.
- the various aspects of the present invention are specifically described below.
- amino acids to be used in accordance with the present invention include amino acids, salts of amino acid, and amino acid derivatives, for example branched amino acids such as leucine, isoleucine, and valine, sulfur-containing amino acids such as cystine and methionine, aromatic amino acids such as phenylalanine and tyrosine, heterocyclic amino acids such as tryptophan and histidine, acidic amino acids such as aspartic acid and glutamic acid, and various amino acid derivatives such as sulfur-containing amino acid derivatives including taurine. These amino acids may be used singly or in combination of two or more thereof.
- the subject hydrous solution of the amino acid(s) is in the solution state or a particle slurry solution state (for example, a slurry containing particles having a mean particle size (Mean Volume Diameter) of 0.1 ⁇ m to 15 ⁇ m), and the solvent may contain ethyl alcohol and the like.
- a particle slurry solution state for example, a slurry containing particles having a mean particle size (Mean Volume Diameter) of 0.1 ⁇ m to 15 ⁇ m
- the solvent may contain ethyl alcohol and the like.
- the amino acids to which the present invention is effectively applied include amino acids relatively slightly soluble in water, such as amino acids with a solubility of 9 g or less in 10 g of water at 20° C.
- the amino acids preferable for the application of the present invention are slightly soluble amino acids.
- the present invention is preferably applied to amino acids with a solubility of 5 g or less in 100 g of water at 20° C.
- the present invention is applicable to leucine, isoleucine, cystine, phenylalanine, tyrosine, tryptophan, and aspartic acid, and salts thereof and derivatives thereof, in particular.
- the amount of the amino acid(s) to be used generally includes but is not specifically limited to 20% by weight to 95% by weight in the dry powder. If necessary, the amount may be at 50% by weight to 95% by weight, 60% by weight to 95% by weight, or 70% by weight to 95% by weight.
- the amount to be used may satisfactorily be determined, taking account of the conditions of product design, namely the balance between the amount of amino acid(s) required as effective ingredients and the specific volume of the dry powder of amino acids.
- the raw material trehalose for use in accordance with the invention includes ⁇ , ⁇ -trehalose, ⁇ , ⁇ -trehalose, and ⁇ , ⁇ -trehalose.
- ⁇ , ⁇ -Trehalose is preferable, because ⁇ , ⁇ -trehalose is a naturally occurring substance and is now not costly. If necessary, the dihydrate thereof with almost no hygroscopicity over time may be used, satisfactorily.
- a commercially available “Treha” (Hayashibara, Co., Ltd.) is listed and may be used.
- the amount of trehalose (on an anhydride basis) is 5% by weight to 80% by weight in the dry powder, satisfactorily. If necessary, the content can be 5% by weight to 50% by weight, 5% by weight to 40% by weight and 5% by weight to 30% by weight.
- the amount of trehalose to be used may be adjusted to the conditions for product design, as described above.
- the trehalose and the amino acid(s) may be mixed together to prepare a mixture solution prior to spray drying. Otherwise, a hydrous solution containing the amino acid(s) as the main components and a hydrous solution containing trehalose as the main component may be simultaneously sprayed together during spray drying. Alternatively, after a hydrous solution containing the amino acid(s) as the main component(s) has been spray dried, a hydrous solution containing trehalose as the main component may be sprayed and/or granulated as a coating agent and a binder, satisfactorily. If necessary, further additives, other than trehalose, may be added satisfactorily as a matter of course.
- the spray drying apparatus for use in accordance with the present invention, commercially available apparatus can be used.
- a spray drying apparatus which has a vertical parallel flow function is preferable.
- the productivity can be maintained, even under drying conditions with dehumidification at low temperature, and the quality of the resulting dry powder can be maintained at a high level, preferably.
- an apparatus capable of blowing a high volume of dry dehumidified gas at 1% RH or less is particularly preferable as the dehumidifying apparatus, which is for example a dry dehumidifier BX series manufactured by Munsters K. K., and HCS series and HCP series manufactured by Nichias Corporation.
- suitable spray drying apparatus include the micromist dryer MD series and the hybrid granulator series manufactured by Fujisaki Electric Co., Ltd., the FSD spray dryer with internal fluid layer as manufactured by Niro Corporation, the fluid granulation spray dryer and L-8 type spray dryer manufactured by O-gawara Chemical Engineering Machine Corporation, and the DL-21 type and GB-21 type manufactured by Yamato Scientific Co., Ltd.
- a spray nozzle capable of generating a liquid droplet (microfine particle, single particle) having a mean particle size (Mean Volume Diameter) of 0.1 ⁇ m or more to less than 20 ⁇ m.
- a spray dryer or a spray dry granulation apparatus with a spray nozzle capable of generating a large volume of liquid droplets having a mean particle size (Mean Volume Diameter) of 0.1 ⁇ m or more to less than 20 ⁇ m, preferably 0.1 ⁇ m to 10 ⁇ m, and more preferably 1 ⁇ m to 8 ⁇ m.
- a dry powder having a mean particle size (Mean Volume Diameter) of 0.1 ⁇ m to 15 ⁇ m, preferably 0.1 ⁇ m to 7 ⁇ m, and more preferably 0.7 ⁇ m to 6 ⁇ m is obtained.
- This is preferable with the respect to the control of the product quality and productivity, because such liquid droplets can be dried under low-temperature conditions within a short time.
- the four-fluid nozzle manufactured by Fujisaki Electric Co., Ltd. which can spray a large volume (for example, 1 kg/min) of liquid droplets of several micrometers (see, U.S. Pat. No. 2,797,080; Chemical Apparatus, 2000, No. 6, pp.
- the three-fluid nozzle manufactured by Fukusen Production Corporation, which can spray a large volume (for example, 150 g/min) of liquid droplets of 1 ⁇ m to 10 ⁇ m (see, Japanese Patent Publication Sho 63-5146) are included.
- the four-fluid nozzle is particularly preferable because a large volume can be sprayed from the nozzle.
- the spray dryer is preferably an apparatus with a granulation function or is additionally mounted with a granulation dryer if the spray dryer does not have such granulation function (referred to as “spray dry granulation apparatus”).
- the resulting apparatus is of a specification to enable the granulated powder (aggregate particle powder) to be finally dried to the desired moisture.
- particles with such a small specific gravity such as those of amino acids for use in accordance with the present invention
- particles (Mean Volume Diameter) of 0.1 ⁇ m to 15 ⁇ m disadvantageously involve difficulty in handling. Therefore, preferably, a granulation dryer is additionally mounted in the inside of the spray dryer or in a state in communication with the spray dryer.
- the granulation size is 20 ⁇ m to 1,000 ⁇ m, and preferably 20 ⁇ m to 500 ⁇ m (Mean Volume Diameter). Satisfactorily, granulation is sometimes effected almost simultaneously with spray drying or in other cases, fluid granulation is effected after spray drying or both fluid granulation and spray drying are effected simultaneously.
- the apparatus can carry out the final drying during granulation or immediately after granulation.
- the conditions such as the outlet temperature (also referred to as “drying temperature” or “exhaust gas temperature”) of the spray dry granulation apparatus, the inlet temperature thereof, the outlet relative humidity thereof and the inlet relative humidity thereof are almost identical to those of spray drying conditions described below.
- the outlet temperature of the spray dry granulation apparatus is 20° C. to less than 97° C., preferably 20 to 80° C., and more preferably 20 to 60° C.
- the outlet relative humidity of the spray dry granulation apparatus is 1% RH to 50% RH, preferably 3% RH to 35% RH, and more preferably 6% RH to 30% RH.
- the inlet temperature of the spray dry granulation apparatus is 60 to 300° C., and preferably 70 to 180° C. Under conditions lower than 60° C., the productivity is undesirably lowered. Under conditions above 300° C., the quality of the resulting dry powder is undesirably deteriorated.
- the inlet relative humidity of the spray dry granulation apparatus of the invention is 35% RH or less, preferably 15% RH or less, more preferably 7% RH or less, and most preferably 1% RH or less.
- Spray drying granulation apparatus with such granulation function include for example the “Hybrid Granulator Series as granulation apparatus on filter cloth with spray drying function equipped” manufactured by Fujisaki Electric Co., Ltd.
- the outlet temperature (also referred to as “drying temperature” or “exhaust gas temperature”) of the spray dryer is 20° C. to less than 97° C., preferably 20 to 80° C., and more preferably 20 to 60° C. At temperatures lower than 20° C., the productivity is undesirably lowered. Furthermore because the melting point of trehalose in the dihydrate form is 97° C., the outlet temperature is preferably set within a range not exceeding the melting point, with respect to quality control.
- the outlet relative humidity of the spray dryer set in the present invention is 1% RH to 50% RH, preferably 1% RH to 35% RH, and more preferably 1% RH to 30% RH.
- the outlet relative humidity of the spray dryer as referred to in accordance with the present invention means the relative humidity in the vicinity of the powder collection part of the spray dryer.
- the outlet relative humidity exhaust gas humidity
- the outlet relative humidity means the relative humidity at the exhaust part thereof.
- the outlet relative humidity means the relative humidity (exhaust gas humidity) in the vicinity of the filter cloth at the powder collection part of the apparatus.
- the inlet temperature of the spray dryer is 60 to 300° C., and preferably 70 to 180° C. Under conditions lower than 60° C., the productivity is undesirably lowered. Under conditions above 300° C., the quality of the resulting dry powder is undesirably deteriorated.
- the inlet relative humidity of the spray dryer of the present invention is 35% RH or less, preferably 15% RH or less, more preferably 7% RH or less, and most preferably 1% RH or less.
- the volume of dry gas for example dry air for use in accordance with the present invention is preferably 0.5 m/min or more, more preferably 1 m/min to 5 m/min, and still more preferably 1 m/min to 3.5 m/min, with respect to the improvement of the productivity of the dry powder.
- the volume of dry air means the air rate (m/min) in the spray dryer or at the cylinder part (the trunk part) of the body of the spray dry granulation apparatus.
- the volume means the filtration rate.
- the liquid transfer rate of the raw material solutions such as the hydrous solution of amino acids and the hydrous trehalose solution can be preset appropriately, in relation with the inlet temperature, the outlet temperature, the exhaust gas humidity, the types of the raw material solutions, the desired particle size and the like.
- the spraying pressure is preferably 0.5 kg/cm 2 or more, more preferably 1 kg/cm 2 to 5 kg/cm 2 , and still more preferably 1 kg/cm 2 to 3 kg/cm 2 .
- the gas to be used in accordance with the invention is preferably air, but may be a gas other than air, depending on the case.
- Inert gases for example nitrogen gas and carbonate gas, can be used.
- an inert gas is effective and may be preferred.
- the moisture content (loss on drying) of the dry powder thus produced is preferably 5 wt. % or less when dried at 60° C. for 5 hours.
- spray drying the hydrous solution containing trehalose and amino acids or the hydrous solution containing amino acids and the hydrous solution containing trehalose in the form of liquid droplets having a mean particle size of 0.1 ⁇ m or more to less than 20 ⁇ m, and preferably 0.1 ⁇ m to 10 ⁇ m the liquid droplet is instantly dried.
- instant drying at a temperature lower than 97° C., and preferably at a temperature of 20 to 60° C. the trehalose in the dry powder exists in a structure of an almost amorphous state.
- the existence in the amorphous state may possibly generate excellent effects such as oral meltability of the dry powder, the solubility thereof, and the taste-masking effect thereof. Furthermore, some of amino acids are observed to have low crystallinity, according to the method of the present invention, which suggests an increase of amorphous materials.
- the dry powder thus produced can be used as it is or as an intermediate material, in the pharmaceutical field of, for example, oral or infusion amino acid preparations specific to individual diseases for subject patients with renal impairment or liver disorders, and the cosmetic field, and the like.
- the dry powder can be used in the form of powders, tablets, and capsules, as individual materials for foods such as sport drinks, diet food materials, health foods and functional foods, and amino acid-series cosmetics.
- the mean particle size of the microfine powders (single particle powder generated from liquid droplet) were measured visually with a microscope, while the mean particle size (Mean Volume Diameter) of the granulated powders were measured with a dry particle size distribution measurement system of laser diffraction & scattering microtruck, 9320 HRA manufactured by Honeywell Co., Ltd.).
- the flow of dehumidified hot air having a relative humidity of 1% RH at 25° C. was preset to 5.5 m 3 /min (filtration rate of about 3 m/min), and spray drying and granulation were carried out with a “HGL-130 type as granulation apparatus on filter cloth with spray drying function equipped” manufactured by Fujisaki Electric Co., Ltd. using the conditions of the inlet temperature of the spray dry granulation apparatus described below as set to 131 to 139° C. and the feed rate of the aqueous solution of amino acids as set to 6.7 to 7.3 kg/hr. With the exhaust gas temperature (outlet temperature) at 49 to 58° C.
- the mean particle size of the microfine powder (single particle powder generated from the liquid droplets) was about 2 ⁇ m to 3 ⁇ m (diameter), as observed with a microscope. Then, the microfine powder was densified under pressure into granules on the filter membrane for particle collection, so that the dry powder granulated as the final product was a powder of amino acids, which had a mean particle size (Mean Volume Diameter) of 40 ⁇ m (moisture content of 4 wt. %).
- the flow of dehumidified hot air having a relative humidity of 1% RH at 25° C. was preset to 5.5 m 3 /min (filtration rate of about 3 m/min), and spray drying and granulation were carried out with a “HGL-130 type as granulation apparatus on filter cloth with spray drying function equipped” manufactured by Fujisaki Electric Co., Ltd., using the conditions of the inlet temperature of the spray dry granulation apparatus described below set to 130 to 137° C., and the supply rate of aqueous amino acids solution set to 6.1 to 7.7 kg/hr. With the exhaust gas temperature (outlet temperature) at 49 to 61° C.
- the mean particle size (diameter) of the microfine powder (single particle powder generated from the liquid droplets) was about 2 ⁇ m to 3 ⁇ m, as observed with a microscope. Then, the microfine powder was densified under pressure into granules on the filter membrane for particle collection, so that the dry powder granulated as the final product was a powder of amino acids, which had a mean particle size (Mean Volume Diameter) of 32 ⁇ m (moisture content of 1 wt. %).
- Leucine, isoleucine, and valine were individually pulverized to a mean particle size (Mean Volume Diameter) of 20 ⁇ m, and were then mixed together uniformly at 47% by weight, 24% by weight and 29% by weight, respectively. Then, 47.8% by weight of the powder of the amino acid mixture, 47.8% by weight of trehalose ⁇ dihydrate (“Treha” manufactured by Hayashibara, Co., Ltd.), and 4.4% by weight of hydroxypropyl cellulose powder were uniformly mixed together.
- Example 1 Example 2 Oral meltability 5 2 3 Bitterness masking 5 2 3 Solubility 5.5 min 6.00 min 14 min Solidification no problem no problem no problem no problem Notes: The oral meltability and the degree of bitterness masking were evaluated, while the scores of those of Comparative Example 2 were ranked as 3. 1. Oral meltability (5: very good; 4: relatively good; 3: normal; 2: slightly poor; 1: poor) 2.
- the granulated powder containing trehalose had great oral meltability, great solubility, and a great effect on bitterness masking.
- the granulated powder containing sugar had good solubility but poor oral meltability without any masking effect of bitterness. Additionally, the granulated powder tasted very powdery and had bad aftertaste.
- the spray dry granulated powder containing trehalose (Example 1) is compared with the mixed powder of the powders and of the same composition (Comparative Example 2).
- the oral meltability and the bitterness-masking effect of the mix powder of the powders of Comparative Example 2 were more or less worse than those of the spray dry granulated powder (Example 1).
- the spray dry granulated powder containing trehalose (Example 1), the mixed powder of the powders (Comparative Example 2) and the individual raw material powders such as trehalose were analyzed by powder X ray diffraction. The results are shown in FIGS. 1 and 2 . It was clearly verified that trehalose in the spray dry granulated powder of Example 1 was in an amorphous state, which apparently makes contributions to the oral meltability and the bitterness-masking effect. Additionally, the spray dry granulated powder (Example 1) lost the crystallinity essential to amino acids. The spray dry granulated powder (Example 1) exhibits partial crystallinity, but contains an amorphous fraction at a high content, when compared with Comparative Example 2.
- a dry powder of amino acids of high quality such as improved oral meltability, solubility, and a taste-masking effect, can be obtained.
Abstract
Dry powders of amino acids which exhibit great oral meltability and solubility, may be produced by spray drying a hydrous liquid of amino acids to produce a powder of amino acids, where the hydrous liquid of amino acids is prepared into the form of microfine liquid droplets in the presence of trehalose for spray drying, to obtain a powder having a mean particle size of 0.1 μm to 15 μm, as well as granulating and drying during the spray drying or after the spray drying, to obtain a granulated powder having a mean particle size of 20 μm to 1,000 μm.
Description
- This application is a continuation of International Patent Application No. PCT/JPO3/01198, filed on Feb. 5, 2003, and claims priority to Japanese Patent Application No.046580/2002, filed on Feb. 22, 2002, and Japanese Patent Application No. 201848/2002, filed on Jul. 10, 2002, all of which are incorporated herein by reference in their entireties.
- 1. Field of the Invention
- The present invention relates to powders of amino acids, which is a microfine or granulated amino acid powder containing trehalose. The present invention further relates to methods for producing such powders.
- 2. Discussion of the Background
- Amino acids, amino acid salts, and amino acid derivatives (simply referred to as amino acids hereinafter) are widely used in medical diets for nutrition supplements, disease-specific amino acid preparations for oral administration and infusion for subject patients with renal impairment and liver disorders, infantile nutritious compositions, diet food materials, health foods, and functional foods. Further, amino acids are used in cosmetics and in veterinary preparations for dosing to animals, after being mixed in feeds and the like.
- Trehalose, when contained in amino acids, not only serves as a saccharide nutrient but also suppresses the bittern taste of amino acids, advantageously, without any occurrence of the Maillard reaction (browning reaction). Therefore, the presence of trehalose therein is recommended. Specifically, those formulations described below are known.
- For example, trehalose-coated (film) powders of amino acids are known, and may be prepared by one of the following methods. In a first method, a binder is added to a powder of amino acids in mixture to prepare granules by an extrusion granulation process, and the granules surfaces are then coated with trehalose as a coating material by fluid granulation. In a second method, trehalose and a binder are added to a powder of amino acids in mixture for coating by fluid granulation, and spraying an aqueous ethanol solution over the resulting coated powder for granulation (see, JP-A-6-227975).
- Furthermore, an amino acid infusion containing trehalose and having the same effects as described above is also known (see, JP-A-6-70718).
- Also known are amino acid food products containing trehalose, which are adjusted to a pH 3.0 to 6.0 by the addition of sour agents such as citric acid so as to prevent flavor deterioration due to heating of the amino acid, or flavor modification or color modification of the amino acid during long-term storage. The test results of heating the hydrous amino acid-containing solution are disclosed (see, JP-A-2000-4836).
- As compositions for use in the suppression of blood amino acid variation following vigorous athletic motion, a hydrous solution of a composition of amino acids and sugar is disclosed, which contains at least 13 types of amino acids and trehalose. The hydrous solution is said to be effective for the improvement of athletic potential and the amelioration of fatigue (see, JP-A-2000-72669).
- As described above, various findings exist about amino acid compositions containing trehalose, but only JP-A-6-227975 describes such a powder. Further, no amino acid powder with a high oral meltability, high solubility, and masked taste is known. In particularly, there remains a need for a dry power of a branched amino acid and a slightly soluble amino acid, which has improved oral meltability and solubility and suppressed bitterness.
- As production methods of dry powders, meanwhile, the spray drying method, hot-air drying method, and freeze-drying method are known. Among them, the spray drying method is capable of producing microfine particles, and is a dry method for recovering a dry powder of spherical and spherical shell-shaped powder, by dispersing a solution or a particle slurry into the form of microfine particles in hot air, where the spray method uses pressure nozzle, rotating disk, and two-fluid nozzle and the like. In many cases, the mean particle size of the dry powder is about 20 μm to 500 μm (see, Handbook of Chemistry and Engineering, revised sixth edition, p. 770, p. 780 (1999), issued by Maruzen), while in the pharmaceutical field, a production example of microfine particles of 10 μm or less is introduced (see, JP-A-9-235238, JP-T-10-500672, and JP-A-11-114027). In recent years, a four-fluid nozzle has been developed, which has enabled mass-scale spray drying with a liquid droplet having a mean particle size of several micrometers (see, Chemical Apparatus, pp.60-65 (June, 2000), and U.S. Pat. No. 2,797,080, and JP-A-2002-17337, etc.).
- Similar to the powders containing microfine amino acids, an inhalation dry composition containing the pharmacologically active component, interferon, as the essential component and containing a hydrophobic amino acid selected from leucine, isoleucine, and valine at 60% or more to less than 100% (mean particle size (volume-based distribution) of 0.1 μm or more to 10 μm or less) is disclosed for the purpose of avoiding the deliquescence of the inhalation dry composition, when left at a high humidity (see, JP-A-9-235238). In Example 2 of JP-A-9-235238, a dry particle powder is obtained as a control, by preparing a solution containing 3.5 g of isoleucine, 0.7 g of serum albumin, 695.8 g of deionized water, and 300 g of ethanol for spray drying, and then spraying the resulting solution with a spray dryer (aerodynamic mean particle size of 0.9897 μm). However, this Example does not include any description of oral meltability, solubility, and taste masking.
- Moreover, it is also desired that the production of powders of amino acids by spray drying in such manner can be done on a mass scale; that the quality can be maintained; and that the oral meltability and solubility of the resulting powders are great. Accordingly, there remains a need for any improved process so as to satisfy these properties.
- Accordingly, it is one object of the present invention to provide novel dry powders (meaning microfine powder or granulated powder) of amino acids, which have great oral meltability and solubility and a high masking effect of the taste.
- It is another object of the present invention to provide novel methods for preparing such powders.
- It is another object of the present invention to provide novel spray drying methods for preparing such powders.
- These and other objects, which will become apparent during the following detailed description, have been achieved by the inventors' discovery that a dry powder of amino acids with great oral meltability and solubility can be produced by a spray dryer capable of preparing an amino acid solution containing trehalose into the form of liquid droplets of several micrometers (particle). Thus, the invention has been achieved and provides the following embodiments:
- (1) A method for producing a powder of amino acids, comprising spray drying a hydrous liquid of amino acids to produce a powder of amino acids, where the hydrous liquid of amino acids is prepared into the form of microfine liquid droplets in the presence of trehalose for spray drying to prepare a powder having a mean particle size (Mean Volume Diameter) of 0.1 μm to 15 μm.
- (2) A method for producing a powder of amino acids, comprising spray drying a hydrous liquid of amino acids to produce a powder of amino acids, where the hydrous liquid of amino acids is prepared into the form of microfine liquid droplets in the presence of trehalose for spray drying, and the resulting powder is then granulated and dried during spray drying or after spray drying, to prepare a granulated powder having a mean particle size (Mean Volume Diameter) of 20 μm to 1,000 μm.
- (3) A method for producing a powder of amino acids as described in (1) or (2), where the trehalose is added to the hydrous liquid of amino acids or the trehalose is prepared in the form of a trehalose solution at a microfine liquid droplet state to be fed into a spray dryer and/or a granulation dryer.
- (4) A method for producing a powder of amino acids as described in (1) through (3), where the exhaust gas temperature during spray drying or granulation drying is less than 97° C.
- (5) A method for producing a powder of amino acids as described in (1) through (4), where the amino acids are slightly soluble amino acids.
- (6) A method for producing a powder of amino acids as described in (5), where the amino acids are branched amino acids.
- (7) A powder of amino acids, as obtained in a manner described in (1) through (6).
- A more complete appreciation of the invention and many of the attendant advantages thereof will be readily obtained as the same become better understood by reference to the following detailed description when considered in connection with the accompanying drawings, wherein:
-
FIG. 1 depicts two X-ray diffraction charts, in which the upper line is the X-ray powder diffraction pattern of the spray dry granulated powder of Example 1 and the lower line is the X-ray powder diffraction pattern of the mixed powder before drying of Comparative Example 2; and -
FIG. 2 depicts three X-ray diffraction charts, in which the upper line is the X-ray diffraction pattern of trehalose; the middle line is the X-ray diffraction pattern of “the mix powder of amino acids” used as the raw materials of Comparative Example 2; and the lower line is the X-ray diffraction pattern of hydroxypropyl cellulose. - Thus, in a first embodiment, the present invention provides novel powders comprising amino acids and methods of producing such powders. The various aspects of the present invention are specifically described below.
- Amino Acids:
- The amino acids to be used in accordance with the present invention include amino acids, salts of amino acid, and amino acid derivatives, for example branched amino acids such as leucine, isoleucine, and valine, sulfur-containing amino acids such as cystine and methionine, aromatic amino acids such as phenylalanine and tyrosine, heterocyclic amino acids such as tryptophan and histidine, acidic amino acids such as aspartic acid and glutamic acid, and various amino acid derivatives such as sulfur-containing amino acid derivatives including taurine. These amino acids may be used singly or in combination of two or more thereof.
- The subject hydrous solution of the amino acid(s) is in the solution state or a particle slurry solution state (for example, a slurry containing particles having a mean particle size (Mean Volume Diameter) of 0.1 μm to 15 μm), and the solvent may contain ethyl alcohol and the like.
- The amino acids to which the present invention is effectively applied include amino acids relatively slightly soluble in water, such as amino acids with a solubility of 9 g or less in 10 g of water at 20° C. Particularly, the amino acids preferable for the application of the present invention are slightly soluble amino acids. The present invention is preferably applied to amino acids with a solubility of 5 g or less in 100 g of water at 20° C. The present invention is applicable to leucine, isoleucine, cystine, phenylalanine, tyrosine, tryptophan, and aspartic acid, and salts thereof and derivatives thereof, in particular.
- The amount of the amino acid(s) to be used generally includes but is not specifically limited to 20% by weight to 95% by weight in the dry powder. If necessary, the amount may be at 50% by weight to 95% by weight, 60% by weight to 95% by weight, or 70% by weight to 95% by weight. The amount to be used may satisfactorily be determined, taking account of the conditions of product design, namely the balance between the amount of amino acid(s) required as effective ingredients and the specific volume of the dry powder of amino acids.
- Trehalose:
- The raw material trehalose for use in accordance with the invention includes α,α-trehalose, α, β-trehalose, and β,β-trehalose. α,α-Trehalose is preferable, because α,α-trehalose is a naturally occurring substance and is now not costly. If necessary, the dihydrate thereof with almost no hygroscopicity over time may be used, satisfactorily. For example, a commercially available “Treha” (Hayashibara, Co., Ltd.) is listed and may be used.
- The amount of trehalose (on an anhydride basis) is 5% by weight to 80% by weight in the dry powder, satisfactorily. If necessary, the content can be 5% by weight to 50% by weight, 5% by weight to 40% by weight and 5% by weight to 30% by weight. The amount of trehalose to be used may be adjusted to the conditions for product design, as described above.
- The trehalose and the amino acid(s) may be mixed together to prepare a mixture solution prior to spray drying. Otherwise, a hydrous solution containing the amino acid(s) as the main components and a hydrous solution containing trehalose as the main component may be simultaneously sprayed together during spray drying. Alternatively, after a hydrous solution containing the amino acid(s) as the main component(s) has been spray dried, a hydrous solution containing trehalose as the main component may be sprayed and/or granulated as a coating agent and a binder, satisfactorily. If necessary, further additives, other than trehalose, may be added satisfactorily as a matter of course.
- Apparatus in Relation With Spray Drying:
- As the spray drying apparatus for use in accordance with the present invention, commercially available apparatus can be used. For example, a spray drying apparatus which has a vertical parallel flow function is preferable. In particular, when a system with a dehumidifying and drying function is used, the productivity can be maintained, even under drying conditions with dehumidification at low temperature, and the quality of the resulting dry powder can be maintained at a high level, preferably. As described below, for example, an apparatus capable of blowing a high volume of dry dehumidified gas at 1% RH or less is particularly preferable as the dehumidifying apparatus, which is for example a dry dehumidifier BX series manufactured by Munsters K. K., and HCS series and HCP series manufactured by Nichias Corporation. Other suitable spray drying apparatus include the micromist dryer MD series and the hybrid granulator series manufactured by Fujisaki Electric Co., Ltd., the FSD spray dryer with internal fluid layer as manufactured by Niro Corporation, the fluid granulation spray dryer and L-8 type spray dryer manufactured by O-gawara Chemical Engineering Machine Corporation, and the DL-21 type and GB-21 type manufactured by Yamato Scientific Co., Ltd.
- In accordance with the present invention, it is important to carry out the spray drying, using a spray nozzle capable of generating a liquid droplet (microfine particle, single particle) having a mean particle size (Mean Volume Diameter) of 0.1 μm or more to less than 20 μm. Specifically, it is important to carry out the drying using a spray dryer or a spray dry granulation apparatus with a spray nozzle capable of generating a large volume of liquid droplets having a mean particle size (Mean Volume Diameter) of 0.1 μm or more to less than 20 μm, preferably 0.1 μm to 10 μm, and more preferably 1 μm to 8 μm. When the liquid droplet is dried, a dry powder having a mean particle size (Mean Volume Diameter) of 0.1 μm to 15 μm, preferably 0.1 μm to 7 μm, and more preferably 0.7 μm to 6 μm is obtained. This is preferable with the respect to the control of the product quality and productivity, because such liquid droplets can be dried under low-temperature conditions within a short time. For example, the four-fluid nozzle manufactured by Fujisaki Electric Co., Ltd., which can spray a large volume (for example, 1 kg/min) of liquid droplets of several micrometers (see, U.S. Pat. No. 2,797,080; Chemical Apparatus, 2000, No. 6, pp. 60-65) and the three-fluid nozzle manufactured by Fukusen Production Corporation, which can spray a large volume (for example, 150 g/min) of liquid droplets of 1 μm to 10 μm (see, Japanese Patent Publication Sho 63-5146) are included. The four-fluid nozzle is particularly preferable because a large volume can be sprayed from the nozzle.
- Granulation:
- Furthermore, the spray dryer is preferably an apparatus with a granulation function or is additionally mounted with a granulation dryer if the spray dryer does not have such granulation function (referred to as “spray dry granulation apparatus”). Then, importantly, the resulting apparatus is of a specification to enable the granulated powder (aggregate particle powder) to be finally dried to the desired moisture. In the case of particles with such a small specific gravity such as those of amino acids for use in accordance with the present invention, particles (Mean Volume Diameter) of 0.1 μm to 15 μm disadvantageously involve difficulty in handling. Therefore, preferably, a granulation dryer is additionally mounted in the inside of the spray dryer or in a state in communication with the spray dryer.
- Appropriate conditions for the granulation size may satisfactorily be selected, depending on the need. For example, the granulation size is 20 μm to 1,000 μm, and preferably 20 μm to 500 μm (Mean Volume Diameter). Satisfactorily, granulation is sometimes effected almost simultaneously with spray drying or in other cases, fluid granulation is effected after spray drying or both fluid granulation and spray drying are effected simultaneously.
- Then, preferably, the apparatus can carry out the final drying during granulation or immediately after granulation. As to the conditions prior to or after granulation, the conditions such as the outlet temperature (also referred to as “drying temperature” or “exhaust gas temperature”) of the spray dry granulation apparatus, the inlet temperature thereof, the outlet relative humidity thereof and the inlet relative humidity thereof are almost identical to those of spray drying conditions described below. In other words, the outlet temperature of the spray dry granulation apparatus is 20° C. to less than 97° C., preferably 20 to 80° C., and more preferably 20 to 60° C. Additionally, the outlet relative humidity of the spray dry granulation apparatus is 1% RH to 50% RH, preferably 3% RH to 35% RH, and more preferably 6% RH to 30% RH. Further, the inlet temperature of the spray dry granulation apparatus is 60 to 300° C., and preferably 70 to 180° C. Under conditions lower than 60° C., the productivity is undesirably lowered. Under conditions above 300° C., the quality of the resulting dry powder is undesirably deteriorated. Furthermore, the inlet relative humidity of the spray dry granulation apparatus of the invention is 35% RH or less, preferably 15% RH or less, more preferably 7% RH or less, and most preferably 1% RH or less. These preferable conditions are selected with the respect to the control of product quality such as the suppression of the Maillard reaction and with the respect to productivity improvement. Spray drying granulation apparatus with such granulation function include for example the “Hybrid Granulator Series as granulation apparatus on filter cloth with spray drying function equipped” manufactured by Fujisaki Electric Co., Ltd.
- Operation Conditions of the Spray Dryer:
- Among the operation conditions of the spray dryer, the outlet temperature (also referred to as “drying temperature” or “exhaust gas temperature”) of the spray dryer is 20° C. to less than 97° C., preferably 20 to 80° C., and more preferably 20 to 60° C. At temperatures lower than 20° C., the productivity is undesirably lowered. Furthermore because the melting point of trehalose in the dihydrate form is 97° C., the outlet temperature is preferably set within a range not exceeding the melting point, with respect to quality control.
- Meanwhile, the outlet relative humidity of the spray dryer set in the present invention is 1% RH to 50% RH, preferably 1% RH to 35% RH, and more preferably 1% RH to 30% RH. The outlet relative humidity of the spray dryer as referred to in accordance with the present invention means the relative humidity in the vicinity of the powder collection part of the spray dryer. For the spray dryer of the vertical parallel flow type, the outlet relative humidity (exhaust gas humidity) means the relative humidity at the exhaust part thereof. For the “Hybrid Granulator Series HGL-130 as granulation apparatus on filter cloth with spray drying function equipped” manufactured by Fujisaki Electric Co., Ltd., for example, the outlet relative humidity means the relative humidity (exhaust gas humidity) in the vicinity of the filter cloth at the powder collection part of the apparatus.
- Herein, the inlet temperature of the spray dryer is 60 to 300° C., and preferably 70 to 180° C. Under conditions lower than 60° C., the productivity is undesirably lowered. Under conditions above 300° C., the quality of the resulting dry powder is undesirably deteriorated. Furthermore, the inlet relative humidity of the spray dryer of the present invention is 35% RH or less, preferably 15% RH or less, more preferably 7% RH or less, and most preferably 1% RH or less. These preferable conditions for the inlet temperature, the outlet temperature, the inlet relative humidity, and the outlet relative humidity are selected with the respect to the control of product quality such as the suppression of the Maillard reaction, and with respect to productivity improvement.
- The volume of dry gas, for example dry air for use in accordance with the present invention is preferably 0.5 m/min or more, more preferably 1 m/min to 5 m/min, and still more preferably 1 m/min to 3.5 m/min, with respect to the improvement of the productivity of the dry powder. Herein, the volume of dry air means the air rate (m/min) in the spray dryer or at the cylinder part (the trunk part) of the body of the spray dry granulation apparatus. For the “Hybrid Granulator HGL-130 as granulation apparatus on filter cloth with spray drying function equipped” manufactured by Fujisaki Electric Co., Ltd., for example, the volume means the filtration rate. Further, the liquid transfer rate of the raw material solutions such as the hydrous solution of amino acids and the hydrous trehalose solution can be preset appropriately, in relation with the inlet temperature, the outlet temperature, the exhaust gas humidity, the types of the raw material solutions, the desired particle size and the like. Additionally, the spraying pressure is preferably 0.5 kg/cm2 or more, more preferably 1 kg/cm2 to 5 kg/cm2, and still more preferably 1 kg/cm2 to 3 kg/cm2.
- Furthermore, the gas to be used in accordance with the invention is preferably air, but may be a gas other than air, depending on the case. Inert gases, for example nitrogen gas and carbonate gas, can be used. In the case of addition of readily oxidizable substances or readily modifiable substances, the use of an inert gas is effective and may be preferred.
- The moisture content (loss on drying) of the dry powder thus produced is preferably 5 wt. % or less when dried at 60° C. for 5 hours. By spray drying the hydrous solution containing trehalose and amino acids or the hydrous solution containing amino acids and the hydrous solution containing trehalose in the form of liquid droplets having a mean particle size of 0.1 μm or more to less than 20 μm, and preferably 0.1 μm to 10 μm, the liquid droplet is instantly dried. By instant drying at a temperature lower than 97° C., and preferably at a temperature of 20 to 60° C., the trehalose in the dry powder exists in a structure of an almost amorphous state. The existence in the amorphous state may possibly generate excellent effects such as oral meltability of the dry powder, the solubility thereof, and the taste-masking effect thereof. Furthermore, some of amino acids are observed to have low crystallinity, according to the method of the present invention, which suggests an increase of amorphous materials.
- The dry powder thus produced can be used as it is or as an intermediate material, in the pharmaceutical field of, for example, oral or infusion amino acid preparations specific to individual diseases for subject patients with renal impairment or liver disorders, and the cosmetic field, and the like. For example, the dry powder can be used in the form of powders, tablets, and capsules, as individual materials for foods such as sport drinks, diet food materials, health foods and functional foods, and amino acid-series cosmetics.
- Other features of the invention will become apparent in the course of the following descriptions of exemplary embodiments which are given for illustration of the invention and are not intended to be limiting thereof.
- Herein, the mean particle size of the microfine powders (single particle powder generated from liquid droplet) were measured visually with a microscope, while the mean particle size (Mean Volume Diameter) of the granulated powders were measured with a dry particle size distribution measurement system of laser diffraction & scattering microtruck, 9320 HRA manufactured by Honeywell Co., Ltd.).
- Water was added to 4.98% by weight of a mixture of branched amino acids having a mean particle size (Mean Volume Diameter) of 20 μm (leucine:isoleucine:valine=47% by weight:24% by weight:29% by weight; manufactured by Ajinomoto Co.); 4.98% by weight trehalose dihydrate (“Treha” manufactured by Hayashibara, Co., Ltd.); 0.45% by weight of hydroxypropyl cellulose; and others, to prepare an aqueous solution of amino acids at a solid concentration of 10.4% by weight.
- The flow of dehumidified hot air having a relative humidity of 1% RH at 25° C. (produced by the dry dehumidifier BX-600 type manufactured by Munsters, K. K.) was preset to 5.5 m3/min (filtration rate of about 3 m/min), and spray drying and granulation were carried out with a “HGL-130 type as granulation apparatus on filter cloth with spray drying function equipped” manufactured by Fujisaki Electric Co., Ltd. using the conditions of the inlet temperature of the spray dry granulation apparatus described below as set to 131 to 139° C. and the feed rate of the aqueous solution of amino acids as set to 6.7 to 7.3 kg/hr. With the exhaust gas temperature (outlet temperature) at 49 to 58° C. and the exhaust gas humidity (outlet relative humidity) at 20% RH to 30% RH, the mean particle size of the microfine powder (single particle powder generated from the liquid droplets) was about 2 μm to 3 μm (diameter), as observed with a microscope. Then, the microfine powder was densified under pressure into granules on the filter membrane for particle collection, so that the dry powder granulated as the final product was a powder of amino acids, which had a mean particle size (Mean Volume Diameter) of 40 μm (moisture content of 4 wt. %).
- An aqueous solution of amino acids (a solid concentration of 5.85% by weight) was prepared at ratios of 4.95% by weight of a powder of branched amino acids of a mean particle size (Mean Volume Diameter) of 20 μm (leucine:isoleucine:valine=47% by weight:24% by weight:29% by weight; manufactured by Ajinomoto Co.); 0.45% by weight of sucrose powder; 0.45% by weight of hydroxypropyl cellulose; and 94.15% by weight of water.
- The flow of dehumidified hot air having a relative humidity of 1% RH at 25° C. (produced by the dry dehumidifier BX-600 type manufactured by Munsters K.K.) was preset to 5.5 m3/min (filtration rate of about 3 m/min), and spray drying and granulation were carried out with a “HGL-130 type as granulation apparatus on filter cloth with spray drying function equipped” manufactured by Fujisaki Electric Co., Ltd., using the conditions of the inlet temperature of the spray dry granulation apparatus described below set to 130 to 137° C., and the supply rate of aqueous amino acids solution set to 6.1 to 7.7 kg/hr. With the exhaust gas temperature (outlet temperature) at 49 to 61° C. and the exhaust gas humidity (outlet relative humidity) at 18% RH to 30% RH, the mean particle size (diameter) of the microfine powder (single particle powder generated from the liquid droplets) was about 2 μm to 3 μm, as observed with a microscope. Then, the microfine powder was densified under pressure into granules on the filter membrane for particle collection, so that the dry powder granulated as the final product was a powder of amino acids, which had a mean particle size (Mean Volume Diameter) of 32 μm (moisture content of 1 wt. %).
- Leucine, isoleucine, and valine. (manufactured by Ajinomoto Co.) were individually pulverized to a mean particle size (Mean Volume Diameter) of 20 μm, and were then mixed together uniformly at 47% by weight, 24% by weight and 29% by weight, respectively. Then, 47.8% by weight of the powder of the amino acid mixture, 47.8% by weight of trehalose●dihydrate (“Treha” manufactured by Hayashibara, Co., Ltd.), and 4.4% by weight of hydroxypropyl cellulose powder were uniformly mixed together.
- The granulated powder samples or powder mixture samples as recovered in Example 1, and Comparative Examples 1 and 2 were evaluated for their oral meltability, solubility, the degree of bitterness, and solidification property. The results are shown in Table 1.
TABLE 1 Evaluation results Comparative Comparative Items Example 1 Example 1 Example 2 Oral meltability 5 2 3 Bitterness masking 5 2 3 Solubility 5.5 min 6.00 min 14 min Solidification no problem no problem no problem
Notes:
The oral meltability and the degree of bitterness masking were evaluated, while the scores of those of Comparative Example 2 were ranked as 3.
1. Oral meltability (5: very good; 4: relatively good; 3: normal; 2: slightly poor; 1: poor)
2. Degree of bitterness masking (5: very good; 4: relatively good; 3: normal; 2: slightly poor; 1: poor)
3. Solubility: 250 ml off water at 16° C. was placed in a 300-ml beaker; an amount of a sample was measured to an amino acid content of 50 mg, and was then placed in the beaker under agitation at 300 rpm with a magnetic stirrer, F-616 Type (Tokyo Glass Kikai, Co., Ltd.), the time until the sample was completely dissolved was determined and is reported.
4. Solidification property: After individual samples were prepared, the samples were pouched and sealed, and were then left to stand for 2 weeks, to observe the solidified state.
- As described above, the granulated powder containing trehalose (Example 1) had great oral meltability, great solubility, and a great effect on bitterness masking. The granulated powder containing sugar (Comparative Example 1) had good solubility but poor oral meltability without any masking effect of bitterness. Additionally, the granulated powder tasted very powdery and had bad aftertaste.
- Herein, the spray dry granulated powder containing trehalose (Example 1) is compared with the mixed powder of the powders and of the same composition (Comparative Example 2). The solubility of the mixed powder of the powders of Comparative Example 2 was similar to the solubility (13.5 minutes) of the “mix powder of amino acids” (leucine:isoleucine:valine=47% by weight:24% by weight:29% by weight) as the raw material of Comparative Example 2 but was apparently poorer than the solubility of the spray dry granulated powder containing trehalose (Example 1). Furthermore, the oral meltability and the bitterness-masking effect of the mix powder of the powders of Comparative Example 2 were more or less worse than those of the spray dry granulated powder (Example 1).
- The spray dry granulated powder containing trehalose (Example 1), the mixed powder of the powders (Comparative Example 2) and the individual raw material powders such as trehalose were analyzed by powder X ray diffraction. The results are shown in
FIGS. 1 and 2 . It was clearly verified that trehalose in the spray dry granulated powder of Example 1 was in an amorphous state, which apparently makes contributions to the oral meltability and the bitterness-masking effect. Additionally, the spray dry granulated powder (Example 1) lost the crystallinity essential to amino acids. The spray dry granulated powder (Example 1) exhibits partial crystallinity, but contains an amorphous fraction at a high content, when compared with Comparative Example 2. - In accordance with the present invention, a dry powder of amino acids of high quality, such as improved oral meltability, solubility, and a taste-masking effect, can be obtained.
- Obviously, numerous modifications and variations of the present invention are possible in light of the above teachings. It is therefore to be understood that, within the scope of the appended claims, the invention may be practiced otherwise than as specifically described herein.
- All patents and other references mentioned above are incorporated in full herein by this reference, the same as if set forth at length.
Claims (20)
1. A method for producing a powder of one or more amino acids, comprising:
(1) spray drying a hydrous liquid comprising at least one amino acid to obtain a powder of said at least one amino acid,
wherein said hydrous liquid comprising said at least one amino acids is prepared into the form of microfine liquid droplets in the presence of trehalose for spray drying to obtain a powder having a mean particle size of 0.1 μm to 15 μm.
2. The method of claim 1 , wherein said trehalose is added to said hydrous liquid comprising said at least one amino acid.
3. The method of claim 1 , wherein said trehalose is prepared into the form of a trehalose solution existing as microfine liquid droplets and is spray dried with said hydrous liquid comprising said at least one amino acid.
4. The method of claim 1 , wherein said spray drying is carried out under a condition of an exhaust gas temperature during spray drying of less than 97° C.
5. The method of claim 1 , wherein said at least one amino acid is one or more slightly soluble amino acids.
6. The method of claim 1 , wherein said at least one amino acid is one or more branched amino acids.
7. The method of claim 1 , wherein said hydrous liquid comprising at least one amino acid is a solution.
8. The method of claim 1 , wherein said hydrous liquid comprising at least one amino acid is a suspension.
9. The method of claim 1 , wherein said hydrous liquid comprising at least one amino acid is an emulsion.
10. A powder of one or more amino acids, wherein said powder is prepared by a process according to claim 1 .
11. A method for producing a powder of one or more amino acids, comprising:
(1) spray drying a hydrous liquid comprising at least one amino acid to obtain a powder of said at least one amino acid,
wherein said hydrous liquid comprising at least one amino acid is prepared into the form of microfine liquid droplets in the presence of trehalose for spray drying, and said powder of said at least one amino acid is then granulated and dried, during spray drying or after spray drying, to obtain a granulated powder having a mean particle size of 20 μm to 1,000 μm.
12. The method of claim 11 , wherein said trehalose is added to said hydrous liquid comprising at least one amino acid.
13. The method of claim 11 , wherein said trehalose is prepared into the form of a trehalose solution existing as microfine liquid droplets and is spray dried and/or a granulated with said hydrous liquid comprising said at least one amino acid.
14. The method of claim 11 , wherein said spray drying or granulation is carried out under a condition of an exhaust gas temperature during spray drying of less than 97° C.
15. The method of claim 11 , wherein said at least one amino acid is a slightly soluble amino acid.
16. The method of claim 11 , wherein said at least one amino acid is a branched amino acid.
17. The method of claim 11 , wherein said hydrous liquid comprising at least one amino acid is a solution.
18. The method of claim 11 , wherein said hydrous liquid comprising at least one amino acid is a suspension.
19. The method of claim 11 , wherein said hydrous liquid comprising at least one amino acid is an emulsion.
20. A powder of one or more amino acids, wherein said powder is prepared by a process according to claim 11.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/168,566 US7662799B2 (en) | 2002-02-22 | 2008-07-07 | Powder of amino acids and method for producing the same |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002046580 | 2002-02-22 | ||
JP046580/2002 | 2002-02-22 | ||
JP201848/2002 | 2002-07-10 | ||
JP2002201848 | 2002-07-10 | ||
PCT/JP2003/001198 WO2003070023A1 (en) | 2002-02-22 | 2003-02-05 | Amino acid powder and process for producing the same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/001198 Continuation WO2003070023A1 (en) | 2002-02-22 | 2003-02-05 | Amino acid powder and process for producing the same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/168,566 Continuation US7662799B2 (en) | 2002-02-22 | 2008-07-07 | Powder of amino acids and method for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050080136A1 true US20050080136A1 (en) | 2005-04-14 |
Family
ID=27759684
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/921,895 Abandoned US20050080136A1 (en) | 2002-02-22 | 2004-08-20 | Powder of amino acids and method for producing the same |
US12/168,566 Expired - Fee Related US7662799B2 (en) | 2002-02-22 | 2008-07-07 | Powder of amino acids and method for producing the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/168,566 Expired - Fee Related US7662799B2 (en) | 2002-02-22 | 2008-07-07 | Powder of amino acids and method for producing the same |
Country Status (9)
Country | Link |
---|---|
US (2) | US20050080136A1 (en) |
EP (1) | EP1479300B1 (en) |
JP (1) | JP4482925B2 (en) |
CN (1) | CN100356871C (en) |
AU (1) | AU2003207244A1 (en) |
BR (1) | BR0306741A (en) |
DE (1) | DE60329744D1 (en) |
MY (1) | MY140392A (en) |
WO (1) | WO2003070023A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1839502A1 (en) * | 2004-12-07 | 2007-10-03 | Ajinomoto Co., Inc. | Fine powder of amino acid and suspension thereof |
US20080028632A1 (en) * | 2006-04-24 | 2008-02-07 | Daniel Py | Needle penetrable and laser resealable lyophilization device and related method |
US20080132604A1 (en) * | 2006-11-30 | 2008-06-05 | Terumo Kabushiki Kaisha | Poly-(alpha-hydroxy acid) composition and method of producing molded article using the same |
US20080172902A1 (en) * | 2006-06-20 | 2008-07-24 | Octapharma Ag | Lyophilisation targeting defined residual moisture by limited desorption energy levels |
US8272411B2 (en) | 2003-04-28 | 2012-09-25 | Medical Instill Technologies, Inc. | Lyophilization method and device |
WO2013109863A1 (en) * | 2012-01-20 | 2013-07-25 | Milk Specialties Company | Method of instantizing amino acids |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004305201A (en) * | 2002-11-27 | 2004-11-04 | Hayashibara Biochem Lab Inc | Method for controlling formation of acrylamide and use of the same |
WO2007022968A1 (en) * | 2005-08-23 | 2007-03-01 | Hans Leweling | Protein composition for treating protein deficiency conditions |
DE502006008291D1 (en) * | 2005-08-23 | 2010-12-23 | Herberger Armand | PROTEIN COMPOSITION FOR TREATING A PHYSIOLOGICALLY CONDITIONAL, CLINICALLY INVALID PROTEIN SUPPLY |
JP5438287B2 (en) * | 2008-05-30 | 2014-03-12 | 日本理化学薬品株式会社 | Slightly soluble amino acid-containing mixed composition, method for producing the same, and skin external preparation |
CN102149374B (en) | 2008-09-09 | 2013-06-12 | 味之素株式会社 | Orally administrable formulation containing branched chain amino acid |
EP2373184A4 (en) * | 2008-12-17 | 2012-08-29 | Igeloesa Nutrition Science Ab | Nutritional supplement with specific amino acid profile |
WO2011043647A1 (en) * | 2009-10-09 | 2011-04-14 | N.V. Nutricia | Amino acid composition with improved dispersibility |
JP5917964B2 (en) * | 2012-03-19 | 2016-05-18 | 富士ゼロックス株式会社 | Tablet, tablet manufacturing method, tablet management device, tablet verification device, and program |
CN102908337B (en) * | 2012-10-12 | 2014-03-05 | 大连医诺生物有限公司 | Microencapsulated amino-acid composition and preparation method of microencapsulated amino-acid composition |
CN103734716A (en) * | 2013-12-16 | 2014-04-23 | 无锡金维氨生物科技有限公司 | Branched chain amino acid |
US10806770B2 (en) | 2014-10-31 | 2020-10-20 | Monash University | Powder formulation |
CN105288638B (en) * | 2015-10-27 | 2018-07-06 | 江苏金维氨生物工程有限公司 | A kind of method for improving branched-chain amino acid pulvis bulk density |
WO2023222797A1 (en) * | 2022-05-18 | 2023-11-23 | Société des Produits Nestlé S.A. | Method for the preparation of a nutritional powder |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5538883A (en) * | 1993-07-20 | 1996-07-23 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Maltose-trehalose converting enzyme |
US6254889B1 (en) * | 1995-07-26 | 2001-07-03 | Kyowa Hakko Kogyo Co., Ltd. | Solid dispersion dosage form of amorphous xanthine derivative and enteric-coating polymer |
US20010006939A1 (en) * | 1997-10-03 | 2001-07-05 | Ralph W. Niven | Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
US6455511B1 (en) * | 1994-09-22 | 2002-09-24 | Quadrant Holdings Cambridge Limited | Compositions for use in rehydration and nutrition during athletic exercise and methods of making same |
US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US20030202978A1 (en) * | 2001-06-08 | 2003-10-30 | Yuh-Fun Maa | Spray freeze-dried compositions |
US6743443B1 (en) * | 1998-10-05 | 2004-06-01 | Eisai Co., Ltd. | Tablets immediately disintegrating in the oral cavity |
US20040214746A1 (en) * | 2001-12-10 | 2004-10-28 | Bosch H. William | Pharmaceutical composition of a tachykinin receptor antagonist |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2797080A (en) * | 1954-03-04 | 1957-06-25 | Gen Electric | Centrifugal mechanism |
JP2797080B2 (en) | 1995-02-16 | 1998-09-17 | 藤崎電機株式会社 | Method and nozzle for injecting liquid into fine particles |
JP2934695B2 (en) * | 1993-01-29 | 1999-08-16 | ヘキスト・マリオン・ルセル株式会社 | Solid preparation |
CN1053324C (en) * | 1994-09-29 | 2000-06-14 | 青岛海藻保健食品开发公司 | Seaweed iodine health-care product and its preparation method |
TW403653B (en) * | 1995-12-25 | 2000-09-01 | Otsuka Pharma Co Ltd | Dry compositions |
US5854846A (en) * | 1996-09-06 | 1998-12-29 | Northrop Grumman Corporation | Wafer fabricated electroacoustic transducer |
CN1247091A (en) * | 1999-07-22 | 2000-03-15 | 中国医学科学院医学生物学研究所 | Freeze-dired attenuated live vaccine for hepatitis A and its preparing process |
JP3566144B2 (en) * | 1999-08-23 | 2004-09-15 | 長谷川香料株式会社 | Stabilized silk fibroin and food and drink containing it |
BR0307049A (en) * | 2002-02-18 | 2004-10-26 | Ajinomoto Kk | Method for producing a dry powder retaining aroma and taste of a hydrated liquid material and dry powder |
JP4667308B2 (en) * | 2006-06-23 | 2011-04-13 | 三井化学株式会社 | Protective sheet for semiconductor wafer dicing and semiconductor wafer dicing method using the same |
-
2003
- 2003-02-05 BR BR0306741-6A patent/BR0306741A/en not_active IP Right Cessation
- 2003-02-05 AU AU2003207244A patent/AU2003207244A1/en not_active Abandoned
- 2003-02-05 EP EP03703198A patent/EP1479300B1/en not_active Expired - Lifetime
- 2003-02-05 JP JP2003568996A patent/JP4482925B2/en not_active Expired - Fee Related
- 2003-02-05 CN CNB038028492A patent/CN100356871C/en not_active Expired - Fee Related
- 2003-02-05 WO PCT/JP2003/001198 patent/WO2003070023A1/en active Application Filing
- 2003-02-05 DE DE60329744T patent/DE60329744D1/en not_active Expired - Lifetime
- 2003-02-20 MY MYPI20030590A patent/MY140392A/en unknown
-
2004
- 2004-08-20 US US10/921,895 patent/US20050080136A1/en not_active Abandoned
-
2008
- 2008-07-07 US US12/168,566 patent/US7662799B2/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US5538883A (en) * | 1993-07-20 | 1996-07-23 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Maltose-trehalose converting enzyme |
US6455511B1 (en) * | 1994-09-22 | 2002-09-24 | Quadrant Holdings Cambridge Limited | Compositions for use in rehydration and nutrition during athletic exercise and methods of making same |
US6254889B1 (en) * | 1995-07-26 | 2001-07-03 | Kyowa Hakko Kogyo Co., Ltd. | Solid dispersion dosage form of amorphous xanthine derivative and enteric-coating polymer |
US20010006939A1 (en) * | 1997-10-03 | 2001-07-05 | Ralph W. Niven | Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
US6743443B1 (en) * | 1998-10-05 | 2004-06-01 | Eisai Co., Ltd. | Tablets immediately disintegrating in the oral cavity |
US20030202978A1 (en) * | 2001-06-08 | 2003-10-30 | Yuh-Fun Maa | Spray freeze-dried compositions |
US20040214746A1 (en) * | 2001-12-10 | 2004-10-28 | Bosch H. William | Pharmaceutical composition of a tachykinin receptor antagonist |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8272411B2 (en) | 2003-04-28 | 2012-09-25 | Medical Instill Technologies, Inc. | Lyophilization method and device |
EP1839502A1 (en) * | 2004-12-07 | 2007-10-03 | Ajinomoto Co., Inc. | Fine powder of amino acid and suspension thereof |
US20070286887A1 (en) * | 2004-12-07 | 2007-12-13 | Ajinomoto Co., Inc | Fine powder of amino acid and suspension thereof |
EP1839502A4 (en) * | 2004-12-07 | 2010-03-24 | Ajinomoto Kk | Fine powder of amino acid and suspension thereof |
US20080028632A1 (en) * | 2006-04-24 | 2008-02-07 | Daniel Py | Needle penetrable and laser resealable lyophilization device and related method |
US7966746B2 (en) * | 2006-04-24 | 2011-06-28 | Medical Instill Technologies, LLC | Needle penetrable and laser resealable lyophilization method |
US8171652B2 (en) | 2006-04-24 | 2012-05-08 | Medical Instill Technologies, Inc. | Penetrable and resealable lyophilization method |
US9222728B2 (en) | 2006-04-24 | 2015-12-29 | Medinstill Development Llc | Penetrable and resealable lyophilization device |
US20080172902A1 (en) * | 2006-06-20 | 2008-07-24 | Octapharma Ag | Lyophilisation targeting defined residual moisture by limited desorption energy levels |
US8769841B2 (en) | 2006-06-20 | 2014-07-08 | Octapharma Ag | Lyophilisation targeting defined residual moisture by limited desorption energy levels |
US20080132604A1 (en) * | 2006-11-30 | 2008-06-05 | Terumo Kabushiki Kaisha | Poly-(alpha-hydroxy acid) composition and method of producing molded article using the same |
WO2013109863A1 (en) * | 2012-01-20 | 2013-07-25 | Milk Specialties Company | Method of instantizing amino acids |
Also Published As
Publication number | Publication date |
---|---|
BR0306741A (en) | 2004-12-28 |
CN100356871C (en) | 2007-12-26 |
US20080275124A1 (en) | 2008-11-06 |
MY140392A (en) | 2009-12-31 |
CN1625346A (en) | 2005-06-08 |
US7662799B2 (en) | 2010-02-16 |
EP1479300A4 (en) | 2005-09-14 |
DE60329744D1 (en) | 2009-12-03 |
EP1479300A1 (en) | 2004-11-24 |
EP1479300B1 (en) | 2009-10-21 |
JP4482925B2 (en) | 2010-06-16 |
JPWO2003070023A1 (en) | 2005-06-09 |
WO2003070023A1 (en) | 2003-08-28 |
AU2003207244A1 (en) | 2003-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7662799B2 (en) | Powder of amino acids and method for producing the same | |
US4670247A (en) | Process for preparing fat-soluble vitamin active beadlets | |
FI80589B (en) | FOERFARANDE FOER FRAMSTAELLNING AV ETT TORRT PORVER FOER EN PHARMACEUTISK MIXTURBEREDNING, VILKET PULVER INNEHAOLLER MIKROINKAPSLAD BACAMPICILLIN-HYDROKLORID. | |
US20050031769A1 (en) | Dry powder which retains savor and flavor and method for producing the same | |
EP0285682B1 (en) | Process for the manufacture of vitamin preparations | |
US20070036868A1 (en) | Particulate vitamin composition | |
IE63911B1 (en) | Morphine-containing composition | |
CN103479582A (en) | Fast wet-massing method for the preparation of calcium-containing compositions | |
US8211471B2 (en) | Process for the production of beadlets | |
EP0075992B1 (en) | Bismuth containing composition and method for the preparation thereof | |
DK2983650T3 (en) | ORAL PHARMACEUTICAL COMPOSITION WITH TASTE MASKED NACETYL CYSTEIN | |
JP2004242509A (en) | Food containing coenzyme q10 and amino acid | |
JP2004269384A (en) | Coated water-absorbing amino acid granule | |
JP2546838B2 (en) | Vitamin preparation manufacturing method | |
US20210046010A1 (en) | Tablets containing arginine at high concentration | |
JPH07173065A (en) | Quickly soluble sodium alginate granule for medical use and its production | |
JPH08319232A (en) | Particulate composition | |
US20230079100A1 (en) | Process for preparing solid formulations comprising a hydrophobic compound dispersible in a cold liquid and relative solid formulations | |
JP2009046436A (en) | Coating method and treated product | |
JPH06303937A (en) | Granular seasoning and its production | |
KR101125453B1 (en) | Solubilizing Compositions of L-Tryptophan and Pharmaceutical preparation therefrom | |
JPS60132987A (en) | Chlorophyll composition | |
JPS61268153A (en) | Sweetener formulation | |
JPH02128654A (en) | Feed additive for ruminant | |
JPS61268154A (en) | Production of dried food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AJINOMOTO CO., INC., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WATANABE, AIJI;KATOUNO, JUNICHI;YOSHIDA, TERUO;AND OTHERS;REEL/FRAME:016100/0452;SIGNING DATES FROM 20040822 TO 20040826 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |